Bivalirudin in Acute Myocardial Infarction

Clinical trial NCT02897037 · UNKNOWN

Trial details

NCT number: NCT02897037
Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Myocardial Infarction

Start date: 2016-11-01
Primary completion: 2017-06-01
Enrollment: 380

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.